chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Malaise, Myalgia, Pyrexia
Clinical narrative: Feeling as really bad; Malaise; Fever; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling as really bad), MALAISE (Malaise), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04AA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced FEELING ABNORMAL (Feeling as really bad), MALAISE (Malaise), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Feeling as really bad), MALAISE (Malaise), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) had not resolved.            The patient reported self-treating with ibuprofen. No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-081270.   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081270:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Swelling, Vaccination site swelling
Clinical narrative: swollen neck; Itchy arm; Itchy neck; Rash; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen neck), PRURITUS (Itchy arm), PRURITUS (Itchy neck), RASH (Rash) and VACCINATION SITE SWELLING (swollen arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced SWELLING (swollen neck), PRURITUS (Itchy arm), PRURITUS (Itchy neck), RASH (Rash) and VACCINATION SITE SWELLING (swollen arm). At the time of the report, SWELLING (swollen neck), PRURITUS (Itchy arm), PRURITUS (Itchy neck), RASH (Rash) and VACCINATION SITE SWELLING (swollen arm) was resolving.            Concomitant medication not provided.  Treatment not provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Neck pain
Clinical narrative: ache across her neck; Left arm soreness; tiredness about half an hour; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (ache across her neck), FATIGUE (tiredness about half an hour) and MYALGIA (Left arm soreness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (tiredness about half an hour). On an unknown date, the patient experienced NECK PAIN (ache across her neck) and MYALGIA (Left arm soreness). At the time of the report, NECK PAIN (ache across her neck) had resolved and FATIGUE (tiredness about half an hour) and MYALGIA (Left arm soreness) outcome was unknown.            This case was linked to MOD-2021-081265 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19-Apr-2021 contained new event details. On 25-May-2021: Follow up received on 25-May-2021 contained no new information.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Pain, Vaccination site macule
Clinical narrative: Pimple on the arm where she had the shot, weird and hurt so bad; Terrible headaches; Achy from head to toe; Eye hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy from head to toe), EYE PAIN (Eye hurt), VACCINATION SITE MACULE (Pimple on the arm where she had the shot, weird and hurt so bad) and HEADACHE (Terrible headaches) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN (Achy from head to toe), EYE PAIN (Eye hurt) and HEADACHE (Terrible headaches). On 19-Apr-2021, the patient experienced VACCINATION SITE MACULE (Pimple on the arm where she had the shot, weird and hurt so bad). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Achy from head to toe), EYE PAIN (Eye hurt), VACCINATION SITE MACULE (Pimple on the arm where she had the shot, weird and hurt so bad) and HEADACHE (Terrible headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: left leg got swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (left leg got swollen) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (left leg got swollen). At the time of the report, PERIPHERAL SWELLING (left leg got swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported.  No treatment was reported.  Patient went to an urgent care and was discharged without any ultrasound done.   This case was linked to US-MODERNATX, INC.-MOD-2021-081295 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081295:2nd  dose case
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Pain in extremity, Vaccination site swelling
Clinical narrative: knuckles left hand started to hurts/pain in thigh; hand started to numb, expressed out like going to numb; joint left hand started to hurts; arm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (knuckles left hand started to hurts/pain in thigh), HYPOAESTHESIA (hand started to numb, expressed out like going to numb), ARTHRALGIA (joint left hand started to hurts) and VACCINATION SITE SWELLING (arm was swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (knuckles left hand started to hurts/pain in thigh), HYPOAESTHESIA (hand started to numb, expressed out like going to numb), ARTHRALGIA (joint left hand started to hurts) and VACCINATION SITE SWELLING (arm was swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (knuckles left hand started to hurts/pain in thigh), HYPOAESTHESIA (hand started to numb, expressed out like going to numb), ARTHRALGIA (joint left hand started to hurts) and VACCINATION SITE SWELLING (arm was swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Limb discomfort, Pain, Pain in extremity
Clinical narrative: Aches; injection site swollen; Bright red and hot; fever of 102.3 degrees Fahrenheit; CHILLS; arm was swollen; could not lift her arm; could not sleep; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep), PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Bright red and hot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE, SPIRONOLACTONE and THYROID (ARMOUR THYROID) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep) and PAIN IN EXTREMITY (pain in arm). On 03-Apr-2021, the patient experienced PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen), VACCINATION SITE ERYTHEMA (Bright red and hot), PYREXIA (fever of 102.3 degrees Fahrenheit), CHILLS (CHILLS) and VACCINATION SITE SWELLING (arm was swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep), PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen), VACCINATION SITE ERYTHEMA (Bright red and hot), PYREXIA (fever of 102.3 degrees Fahrenheit), CHILLS (CHILLS), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE SWELLING (arm was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Aches; injection site swollen; Bright red and hot; fever of 102.3 degrees Fahrenheit; CHILLS; arm was swollen; could not lift her arm; could not sleep; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep), PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Bright red and hot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE, SPIRONOLACTONE and THYROID (ARMOUR THYROID) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep) and PAIN IN EXTREMITY (pain in arm). On 03-Apr-2021, the patient experienced PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen), VACCINATION SITE ERYTHEMA (Bright red and hot), PYREXIA (fever of 102.3 degrees Fahrenheit), CHILLS (CHILLS) and VACCINATION SITE SWELLING (arm was swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (could not lift her arm), INSOMNIA (could not sleep), PAIN (Aches), VACCINATION SITE SWELLING (injection site swollen), VACCINATION SITE ERYTHEMA (Bright red and hot), PYREXIA (fever of 102.3 degrees Fahrenheit), CHILLS (CHILLS), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE SWELLING (arm was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Erythema, Pruritus
Clinical narrative: Earache (right ear); Bit of redness on the left arm; bit of itchness on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Earache (right ear)), ERYTHEMA (Bit of redness on the left arm) and PRURITUS (bit of itchness on the left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Mar-2021, the patient experienced EAR PAIN (Earache (right ear)), ERYTHEMA (Bit of redness on the left arm) and PRURITUS (bit of itchness on the left arm). At the time of the report, EAR PAIN (Earache (right ear)) had resolved and ERYTHEMA (Bit of redness on the left arm) and PRURITUS (bit of itchness on the left arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing was delayed on an unknown date.       This case was linked to MOD-2021-081317 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: tingling sensation and numbness in legs and hands; Tingling sensation and numbness in legs and hands; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation and numbness in legs and hands) and HYPOAESTHESIA (Tingling sensation and numbness in legs and hands) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling sensation and numbness in legs and hands) and HYPOAESTHESIA (Tingling sensation and numbness in legs and hands). At the time of the report, PARAESTHESIA (tingling sensation and numbness in legs and hands) and HYPOAESTHESIA (Tingling sensation and numbness in legs and hands) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medication was reported. No treatment drug was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms
Clinical narrative: Cramping on  lower legs; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramping on  lower legs) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O18B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Allergy to feathers, Allergy to animal (animal fur) and Dust allergy. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and SALBUTAMOL (ALBUTEROL HFA) for Asthma.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced HEADACHE (Headache). On 12-Apr-2021, the patient experienced MUSCLE SPASMS (Cramping on  lower legs). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Cramping on  lower legs) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Dizziness, Erythema, Flushing
Clinical narrative: Lightheadedness; facial redness; flushing; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.    Co-suspect product included non-company product HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) for an unknown indication.    Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing). At the time of the report, DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include water.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Erythema, Feeling abnormal, Impaired work ability, Influenza like illness
Clinical narrative: redness; warm to touch; Flu like symptoms; low appetite; not feeling right; being a bit slow at work; bumpy spots on the arm; swelling at injection site; pain in the arm; aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE MASS (bumpy spots on the arm), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch) and DECREASED APPETITE (low appetite) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE MASS (bumpy spots on the arm). On 20-Apr-2021, the patient experienced DECREASED APPETITE (low appetite), FEELING ABNORMAL (not feeling right) and IMPAIRED WORK ABILITY (being a bit slow at work). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain in the arm) and MYALGIA (aches). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain in the arm) and MYALGIA (aches) had resolved and VACCINATION SITE MASS (bumpy spots on the arm), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch), DECREASED APPETITE (low appetite), FEELING ABNORMAL (not feeling right) and IMPAIRED WORK ABILITY (being a bit slow at work) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site mass, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: redness; warm to touch; Flu like symptoms; low appetite; not feeling right; being a bit slow at work; bumpy spots on the arm; swelling at injection site; pain in the arm; aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE MASS (bumpy spots on the arm), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch) and DECREASED APPETITE (low appetite) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE MASS (bumpy spots on the arm). On 20-Apr-2021, the patient experienced DECREASED APPETITE (low appetite), FEELING ABNORMAL (not feeling right) and IMPAIRED WORK ABILITY (being a bit slow at work). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain in the arm) and MYALGIA (aches). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain in the arm) and MYALGIA (aches) had resolved and VACCINATION SITE MASS (bumpy spots on the arm), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm to touch), DECREASED APPETITE (low appetite), FEELING ABNORMAL (not feeling right) and IMPAIRED WORK ABILITY (being a bit slow at work) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Tiredness) and HEADACHE (Headache) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FATIGUE (Tiredness) and HEADACHE (Headache). On 21-Mar-2021, PAIN IN EXTREMITY (Sore arm), FATIGUE (Tiredness) and HEADACHE (Headache) had resolved.            Concomitant medications included Hormone IUD. No treatment information provided.   This case was linked to MOD-2021-081308 (E2B Linked Report).; Sender's Comments:  MOD-2021-081308:for 2nd dose
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Little itchy on redness area; Redness over injection site which is big about 2.5 cm diameter and still there; Soreness of left arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Little itchy on redness area), INJECTION SITE PAIN (Soreness of left arm) and INJECTION SITE ERYTHEMA (Redness over injection site which is big about 2.5 cm diameter and still there) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INJECTION SITE PAIN (Soreness of left arm). On 10-Apr-2021, the patient experienced INJECTION SITE PRURITUS (Little itchy on redness area) and INJECTION SITE ERYTHEMA (Redness over injection site which is big about 2.5 cm diameter and still there). At the time of the report, INJECTION SITE PRURITUS (Little itchy on redness area), INJECTION SITE PAIN (Soreness of left arm) and INJECTION SITE ERYTHEMA (Redness over injection site which is big about 2.5 cm diameter and still there) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported  No treatment medication details was reported   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up information was received on 20-May-2021: Changed events outcome from unknown to recovering/resolving.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rashes all over the body; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Apr-2021 and was forwarded to Moderna on 20-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes all over the body) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rashes all over the body). At the time of the report, RASH (Rashes all over the body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter. The patient consulted doctor and was prescribed antihistamine (unspecified).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Non-significant follow up
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Eye swelling
Clinical narrative: Swollen eyes; Pain in the eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swollen eyes) and EYE PAIN (Pain in the eyes) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced EYE SWELLING (Swollen eyes) and EYE PAIN (Pain in the eyes). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, EYE SWELLING (Swollen eyes) and EYE PAIN (Pain in the eyes) had not resolved. Not Provided          No concomitant product was reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Paraesthesia, Paraesthesia oral
Clinical narrative: metallic taste; tingling up to the eldbows on both arms, chin, back of both legs, mouth; tingling up to the eldbows on both arms, chin, back of both legs, mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste), PARAESTHESIA (tingling up to the eldbows on both arms, chin, back of both legs, mouth) and PARAESTHESIA ORAL (tingling up to the eldbows on both arms, chin, back of both legs, mouth) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced DYSGEUSIA (metallic taste), PARAESTHESIA (tingling up to the eldbows on both arms, chin, back of both legs, mouth) and PARAESTHESIA ORAL (tingling up to the eldbows on both arms, chin, back of both legs, mouth). At the time of the report, DYSGEUSIA (metallic taste), PARAESTHESIA (tingling up to the eldbows on both arms, chin, back of both legs, mouth) and PARAESTHESIA ORAL (tingling up to the eldbows on both arms, chin, back of both legs, mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatments were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.  It was reported that patient again presented those symptoms almost 2 weeks since vaccination.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy) and RASH (rash on legs that looked like measles it is now spreading to neck) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced RASH PRURITIC (itchy) and RASH (rash on legs that looked like measles it is now spreading to neck). At the time of the report, RASH PRURITIC (itchy) and RASH (rash on legs that looked like measles it is now spreading to neck) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications provided. Treatment included diphenhydramine. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypersensitivity, Nausea, Pyrexia
Clinical narrative: nurse told her the rash looks like an allergic reaction; Rash on the arms, legs and thigh; Fever; Tiredness; Nausea; Headache; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction), PYREXIA (Fever), the first episode of HEADACHE (Headache), the second episode of FATIGUE (Tiredness) and NAUSEA (Nausea) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced the first episode of HEADACHE (Headache) and the first episode of FATIGUE (Tiredness). On 15-Apr-2021, the patient experienced PYREXIA (Fever), the second episode of FATIGUE (Tiredness), NAUSEA (Nausea) and the second episode of HEADACHE (Headache). On 19-Apr-2021, the patient experienced HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction) and RASH (Rash on the arms, legs and thigh). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date for Rash, at an unspecified dose and frequency; HYDROCORTISONE ongoing since an unknown date for Rash, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 18-Apr-2021, PYREXIA (Fever), the last episode of FATIGUE (Tiredness), NAUSEA (Nausea) and the last episode of HEADACHE (Headache) had resolved. At the time of the report, HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction) outcome was unknown and RASH (Rash on the arms, legs and thigh) was resolving. Not Provided          Concomitant medication included: Hormone IUD.   This case was linked to MOD-2021-081298 (E2B Linked Report).; Sender's Comments:  MOD-2021-081298:First dose
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: nurse told her the rash looks like an allergic reaction; Rash on the arms, legs and thigh; Fever; Tiredness; Nausea; Headache; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction), PYREXIA (Fever), the first episode of HEADACHE (Headache), the second episode of FATIGUE (Tiredness) and NAUSEA (Nausea) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced the first episode of HEADACHE (Headache) and the first episode of FATIGUE (Tiredness). On 15-Apr-2021, the patient experienced PYREXIA (Fever), the second episode of FATIGUE (Tiredness), NAUSEA (Nausea) and the second episode of HEADACHE (Headache). On 19-Apr-2021, the patient experienced HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction) and RASH (Rash on the arms, legs and thigh). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date for Rash, at an unspecified dose and frequency; HYDROCORTISONE ongoing since an unknown date for Rash, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 18-Apr-2021, PYREXIA (Fever), the last episode of FATIGUE (Tiredness), NAUSEA (Nausea) and the last episode of HEADACHE (Headache) had resolved. At the time of the report, HYPERSENSITIVITY (nurse told her the rash looks like an allergic reaction) outcome was unknown and RASH (Rash on the arms, legs and thigh) was resolving. Not Provided          Concomitant medication included: Hormone IUD.   This case was linked to MOD-2021-081298 (E2B Linked Report).; Sender's Comments:  MOD-2021-081298:First dose
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Swelling
Clinical narrative: redness came back; it was really hot; swelling the size of the golf ball; arm was hurting; arm was swollen; arm was red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), SWELLING (arm was swollen), ERYTHEMA (arm was red), ERYTHEMA (redness came back) and FEELING HOT (it was really hot) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting), SWELLING (arm was swollen) and ERYTHEMA (arm was red). On 16-Apr-2021, the patient experienced ERYTHEMA (redness came back), FEELING HOT (it was really hot) and SWELLING (swelling the size of the golf ball). The patient was treated with CORTISONE ACETATE (CORTISONE [CORTISONE ACETATE]) at an unspecified dose and frequency. On 10-Apr-2021, PAIN IN EXTREMITY (arm was hurting), SWELLING (arm was swollen) and ERYTHEMA (arm was red) had resolved. At the time of the report, ERYTHEMA (redness came back), FEELING HOT (it was really hot) and SWELLING (swelling the size of the golf ball) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: diagnosed with COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with COVID) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced COVID-19 (diagnosed with covid). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Apr-2021, COVID-19 (diagnosed with covid) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The doctor asked patient to take Tylenol and Sudafed if needed and get quarantined until symptoms go away. Patient's quarantine got finished on 14-Apr-2021. Patient's second dose of Moderna was scheduled on 22Apr2021.  No other relevant concomitant medication were reported. Tylenol and Sudafed were taken as treatment.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up contains nonsignificant information. Patient declined further follow up.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID19) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced COVID-19 (tested positive for COVID19). At the time of the report, COVID-19 (tested positive for COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment related information was reported. Patient wanted to know if patient could go ahead and get the second dose for which patient was due on 20-Apr-2021.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache, Nausea
Clinical narrative: weakness; dizziness; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, ASTHENIA (weakness), DIZZINESS (dizziness), NAUSEA (nausea) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided. Treatment medication not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Myalgia
Clinical narrative: Dry cough; headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), HEADACHE (headache) and MYALGIA (body aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 002B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Dry cough), HEADACHE (headache) and MYALGIA (body aches). The patient was treated with IBUPROFEN at a dose of 1 dosage form and SUMATRIPTAN (IMITREX [SUMATRIPTAN]) at a dose of 1 dosage form. At the time of the report, COUGH (Dry cough), HEADACHE (headache) and MYALGIA (body aches) outcome was unknown. Not Provided          There were no concomitant medications provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Discomfort; itchiness in the site of injection; slight pain from my underarm, into my forearm; had some redness in the area where the vaccine took place, and a little swollen; had some redness in the area where the vaccine took place; This spontaneous case was reported by a patient and describes the occurrence of DISCOMFORT (Discomfort), VACCINATION SITE PRURITUS (itchiness in the site of injection), AXILLARY PAIN (slight pain from my underarm, into my forearm), VACCINATION SITE SWELLING (had some redness in the area where the vaccine took place, and a little swollen) and VACCINATION SITE ERYTHEMA (had some redness in the area where the vaccine took place) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Rotator cuff syndrome. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for Rotator cuff syndrome.    On 12-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced DISCOMFORT (Discomfort), VACCINATION SITE PRURITUS (itchiness in the site of injection), AXILLARY PAIN (slight pain from my underarm, into my forearm), VACCINATION SITE SWELLING (had some redness in the area where the vaccine took place, and a little swollen) and VACCINATION SITE ERYTHEMA (had some redness in the area where the vaccine took place). At the time of the report, DISCOMFORT (Discomfort), VACCINATION SITE PRURITUS (itchiness in the site of injection), AXILLARY PAIN (slight pain from my underarm, into my forearm), VACCINATION SITE SWELLING (had some redness in the area where the vaccine took place, and a little swollen) and VACCINATION SITE ERYTHEMA (had some redness in the area where the vaccine took place) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Intentional product use issue
Clinical narrative: earache in her right ear returned after receiving her second Moderna dose; 2nd dose administered after 37 days; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (earache in her right ear returned after receiving her second Moderna dose) and INTENTIONAL PRODUCT USE ISSUE (2nd dose administered after 37 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced EAR PAIN (earache in her right ear returned after receiving her second Moderna dose) and INTENTIONAL PRODUCT USE ISSUE (2nd dose administered after 37 days). On 16-Apr-2021, INTENTIONAL PRODUCT USE ISSUE (2nd dose administered after 37 days) had resolved. At the time of the report, EAR PAIN (earache in her right ear returned after receiving her second Moderna dose) had not resolved. Not Provided          No concomitant medications were reported.  Patient reported that  she has spoken to her physician again, and he believes her earache is related to "allergies."  Patient reports her physician could not definitively determine if there is a causal relationship between her symptoms and the Moderna COVID-19 Vaccine.   This case was linked to MOD-2021-081289 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Oropharyngeal pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: slight sore throat; gigantic area at injection site; very hot at injection site; dizziness; swelled up at injection site; tired , body is uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness) and VACCINATION SITE SWELLING (swelled up at injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness), VACCINATION SITE SWELLING (swelled up at injection site) and FATIGUE (tired , body is uncomfortable). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (slight sore throat), VACCINATION SITE REACTION (gigantic area at injection site), VACCINATION SITE WARMTH (very hot at injection site), DIZZINESS (dizziness), VACCINATION SITE SWELLING (swelled up at injection site) and FATIGUE (tired , body is uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.